Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Arzerra

Genmab pulls plug on Phase III Arzerra trial

November 24, 2015 Manufacturing and Production, Research and Development Arzerra, Genmab, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma, ofatumumab, phase III, phase III failure

Genmab has stopped a Phase III study of its CD20-directed monoclonal antibody Arzerra, after it was shown to be unlikely …
News

OmniaMed UK appoints new senior management

November 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OmniaMed has strengthened its senior management team by appointing Dr Clive Deverson as managing director and Dr Colin Griffin as …
Appointment
merck-sharp--dohme-corp

MSD launches new antibiotic in the UK

November 23, 2015 Manufacturing and Production, Research and Development

Merck (MSD) has launched the new intravenous antibiotic Zerbaxa (ceftolozane/tazobactam) in the UK, for the treatment of complicated intra-abdominal infections …
News
tablets_red

Take the Pharmafocus reader survey today

November 23, 2015 Manufacturing and Production, Research and Development

As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …
Feature
pfizer_hq_new_york_dark

Pfizer and Allergan confirm record $160 billion merger

November 23, 2015 Manufacturing and Production, Research and Development

Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …
News
Takeda oncology

FDA approves Takeda’s Ninlaro for multiple myeloma

November 23, 2015 Manufacturing and Production, Research and Development Takeda, myeloma

The US Food and Drug Administration (FDA) has approved Takeda’s Ninlaro (ixazomib) for use in combination with lenalidomide and dexamethasone …
News
cosentyx_logo

Novartis bags two EU Cosentyx approvals

November 23, 2015 Research and Development, Sales and Marketing

The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …
News
amgen_flag

European Commission approves Amgen’s cancer drug Kyprolis in combo therapy

November 20, 2015 Research and Development, Sales and Marketing

The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …
News
ema_logo

Bioproject’s narcolepsy treatment recommended for European approval

November 20, 2015 Research and Development, Sales and Marketing

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bioproject’s Wakix (pitolisant) for the treatment of narcolepsy …
News
ema_inside

Biogen’s Enbrel biosimilar gets positive CHMP opinion

November 20, 2015 Research and Development, Sales and Marketing

The Committee for Medicinal Products for Human Use (CHMP) today gave a positive opinion to Benepali- the first biosimilar version …
News
martin_shkreli_smaller_same

Turing boss Shkreli joins KaloBios as CEO; takes 70% of shares

November 20, 2015 Medical Communications, Research and Development

KaloBios Pharmaceuticals has announced the appointment of Turing CEO Martin Shkreli as its own new CEO and his election as …
Appointment
dr_allan_dunton

Alan Dunton appointed senior vice president at Purdue Pharma

November 20, 2015 Manufacturing and Production, Medical Communications, Research and Development

Purdue Pharma LP has announced the appointment of Alan Dunton, MD, to the role of senior vice president of Research …
Appointment
keytruda

Lilly and Merck extend immuno-oncology collaboration

November 20, 2015 Medical Communications, Research and Development Eli Lilly, Merck

Eli Lilly and Merck have announced the extension of their existing collaboration to evaluate the safety and efficacy of the …
News
bayercross3

Bayer awaits FDA decision on new contraceptive

November 20, 2015 Medical Communications, Research and Development

Bayer has submitted a new drug application (NDA) to the FDA, seeking approval for LCS-16, an investigational hormonal intrauterine device …
News
nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015 Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026